Injectable particle
AssigneeDavid Wong
InventorDavid Wong
Life of this patent
Estimating the term…
Abstract
The present invention provides an injectable particle comprising dasatinib acetate and a hyaluronic acid. The hyaluronic acid may be acetylated or sulfated. The particle is for the use of cancer therapy. The injectable particle may further comprises an acid, wherein the acid is dispersed evenly in the matrix of the injectable particle.
Claims10
An injectable particle comprising dasatinib acetate and hyaluronic acid.
An injectable particle comprising dasatinib acetate, a hyaluronic acid and a surfactant, wherein the surfactant is selected from the group consisting of sodium lauryl sulfate and polysorbate 80.
An injectable particle comprising dasatinib acetate, acetylated hyaluronic acid, polysorbate 80 and rosin acids.
Dependencies are inferred from the claim text.